RankingsPricing
  1. JP-listed companies
  2. Immuno-Biological Laboratories Co., Ltd.
  3. Financials
  4. Cash from operations

Immuno-Biological Laboratories Co., Ltd.【JP:4570】

Market cap
¥17B
P/E ratio
64x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 2025183+37.17%
Mar 31, 2024134+405.61%
Mar 31, 202326-128.39%
Mar 31, 2022-93-51.99%
Mar 31, 2021-194-68.11%
Mar 31, 2020-609+149.55%
Mar 31, 2019-244-430.32%
Mar 31, 201874-232.14%
Mar 31, 2017-56+229.05%
Mar 31, 2016-17-84.42%
Mar 31, 2015-109

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)